Equillium, Inc. (EQ) Social Stream

Featured Post From StockTwits About EQ

$EQ New Press Release:

Equillium to Present at the BTIG Virtual Biotechnology Conference

Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, announced today that it will present at the BTIG Virtual Biotechnology Conference, taking place August 9 & 10, 2021. Bruce Steel, Equillium’s chief executive officer, and Dolca Thomas, M.D., Equillium’s executive vice president of research and development and chief medical officer, will provide a high-level overview of the Company’s clinical focus befo (...)

https://wchr.one/104093